Andrei Gorgos
Papers
1
Total Citations
24
H-Index
1
About
Andrei Gorgos is a leading figure in the field of radiation oncology, with a focused expertise in the treatment of early-stage non-small cell lung cancer (NSCLC). His most impactful work centers on the application of robotic stereotactic ablative radiation therapy (SABR), a highly precise technique that delivers targeted, high-dose radiation to tumors while sparing healthy tissue. Gorgos’s seminal 2015 study, which has garnered 24 citations, provides critical long-term data on quality-of-life outcomes for patients treated with this advanced modality. This research demonstrated that robotic SABR not only achieves excellent local tumor control but also preserves patients’ functional well-being, challenging older assumptions about radiation’s side effects. By rigorously documenting patient-reported outcomes over extended follow-up periods, Gorgos has helped establish robotic SABR as a standard-of-care option for early-stage NSCLC, particularly for those who are not surgical candidates. His work bridges the gap between technological innovation and patient-centered care, offering a compelling evidence base that has influenced clinical guidelines and inspired further investigation into hypofractionated radiation protocols. Gorgos remains a key voice in advancing non-invasive, high-precision cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1